Mike Moyer
Host, LifeSci Advisors, Investor Relations
Replay available
Protalix BioTherapeutics, Inc. (DE) (PLX) Q1 2025 Earnings Call
Protalix BioTherapeutics, Inc. (DE) (AMEX: PLX) Q1 2025 earnings conference call, held 2025-05-09. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dror Bashan
President and CEO, Protallix Biotherapeutics
Ayal Rubin
Senior Vice President and Chief Financial Officer
John Vandermorsten
Analyst, Zacks Investment Research
Ben Akshashudi
Analyst, Parental Securities
Dar Vashish
Private Investor
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Protalix Biotherapeutics, Inc. (de).
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:03.656 Good morning, ladies and gentlemen, and welcome to the Protallix Biotherapeutics First 00:00:03.656 -- 00:00:07.762 Quarter 2025 Financial and Business Results Conference Call. 00:00:07.762 -- 00:00:10.606 As a reminder, this conference is being recorded. 00:00:10.606 -- 00:00:14.512 I will now turn the conference over to our host, Mike Moyer of LifeSci Advisors, Investor 00:00:14.512 -- 00:00:17.196 Relations for Protallix. Thank you. Please go ahead. 00:00:17.196 -- 00:00:18.918 Thank 00:00:18.918 -- 00:00:22.559 you, operator, and welcome to the Protallix Biotherapeutics First Quarter. 00:00:22.559 -- 00:00:26.105 2025 Financial Results and Business Update Conference Call. 00:00:26.105 -- 00:00:30.793 With me today are Dror Bashan, President and CEO of Bratallix, and Ayal Rubin, Senior 00:00:30.793 -- 00:00:33.958 Vice President and Chief Financial Officer. 00:00:33.958 -- 00:00:38.245 Press release announcing the financial results for the quarter and corporate updates 00:00:38.245 -- 00:00:41.130 was issued this morning and is available now on the Bratallix website. 00:00:41.130 -- 00:00:44.415 Please take a moment to read the disclaimer and forward-looking statements in the press 00:00:44.415 -- 00:00:48.749 release. The earnings released in this teleconference include forward-looking statements 00:00:48.749 -- 00:00:52.274 These forward-looking statements are subject to known and unknown risks and uncertainties 00:00:52.274 -- 00:00:55.678 that may cause actual results to differ materially from the statements made. 00:00:55.678 -- 00:00:59.083 Factors that could cause actual results to differ are described in the disclaimer and 00:00:59.083 -- 00:01:02.507 in Protox's filings with the U.S. Securities and Exchange Commission. ...